These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 33583579)
1. Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study. Baandrup L; Dehlendorff C; Hertzum-Larsen R; Hannibal CG; Kjaer SK Gynecol Oncol; 2021 May; 161(2):458-462. PubMed ID: 33583579 [TBL] [Abstract][Full Text] [Related]
2. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study. Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545 [TBL] [Abstract][Full Text] [Related]
3. Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017. Faber MT; Horsbøl TA; Baandrup L; Dalton SO; Kjaer SK Gynecol Oncol; 2022 Jan; 164(1):98-104. PubMed ID: 34763941 [TBL] [Abstract][Full Text] [Related]
4. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study. Baandrup L Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052 [TBL] [Abstract][Full Text] [Related]
5. Socioeconomic status and epithelial ovarian cancer survival in Sweden. Weiderpass E; Oh JK; Algeri S; Bellocco R Cancer Causes Control; 2014 Aug; 25(8):1063-73. PubMed ID: 24906473 [TBL] [Abstract][Full Text] [Related]
6. History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study. Hannibal CG; Kjaer SK; Galanakis M; Hertzum-Larsen R; Maltesen T; Baandrup L Gynecol Oncol; 2024 Mar; 182():1-6. PubMed ID: 38246041 [TBL] [Abstract][Full Text] [Related]
7. Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010. Ibfelt EH; Dalton SO; Høgdall C; Fagö-Olsen CL; Steding-Jessen M; Osler M; Johansen C; Frederiksen K; Kjær SK Cancer Epidemiol; 2015 Jun; 39(3):353-9. PubMed ID: 25841586 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of marital status on survival of women with epithelial ovarian cancer. Mahdi H; Kumar S; Munkarah AR; Abdalamir M; Doherty M; Swensen R Psychooncology; 2013 Jan; 22(1):83-8. PubMed ID: 21919121 [TBL] [Abstract][Full Text] [Related]
9. Socioeconomic status and survival of cirrhosis patients: a Danish nationwide cohort study. Jepsen P; Vilstrup H; Andersen PK; Sørensen HT BMC Gastroenterol; 2009 May; 9():35. PubMed ID: 19450284 [TBL] [Abstract][Full Text] [Related]
10. Aspects of survival from colorectal cancer in Denmark. Iversen LH Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726 [TBL] [Abstract][Full Text] [Related]
11. Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012. Edwards HM; Noer MC; Sperling CD; Nguyen-Nielsen M; Lundvall L; Christensen IJ; Høgdall C Acta Oncol; 2016 Jun; 55 Suppl 2():36-43. PubMed ID: 27355258 [TBL] [Abstract][Full Text] [Related]
12. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study. Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381 [TBL] [Abstract][Full Text] [Related]
13. Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study. Dahm-Kähler P; Holmberg E; Holtenman M; Rådestad AF; Borgfeldt C; Hjerpe E; Marcickiewicz J; Bjurberg M; Tholander B; Hellman K; Kjølhede P; Högberg T; Rosenberg P; Åvall-Lundqvist E; Stålberg K Gynecol Oncol; 2021 Apr; 161(1):244-250. PubMed ID: 33581846 [TBL] [Abstract][Full Text] [Related]
14. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002. Hannibal CG; Cortes R; Engholm G; Kjaer SK Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210 [TBL] [Abstract][Full Text] [Related]
15. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132 [TBL] [Abstract][Full Text] [Related]
16. Increased disease-free and relative survival in advanced ovarian cancer after centralized primary treatment. Palmqvist C; Staf C; Mateoiu C; Johansson M; Albertsson P; Dahm-Kähler P Gynecol Oncol; 2020 Nov; 159(2):409-417. PubMed ID: 32943206 [TBL] [Abstract][Full Text] [Related]
17. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study. Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177 [TBL] [Abstract][Full Text] [Related]
18. Impact of socioeconomic status on survival in patients with ovarian cancer. Gardy J; Dejardin O; Thobie A; Eid Y; Guizard AV; Launoy G Int J Gynecol Cancer; 2019 May; 29(4):792-801. PubMed ID: 30712018 [TBL] [Abstract][Full Text] [Related]
19. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study. Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583 [TBL] [Abstract][Full Text] [Related]